ProPhase Labs Inc (NASDAQ:PRPH) currently has a daily average trading volume of 2.30M but it saw 2796530 shares traded in last market. With a market cap of 11.92M USD, the company’s current market price of $0.29 came falling about -12.42 while comparing to the previous closing price of $0.33. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.45 and as low as $0.22.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which initiated the stock as “Buy” in its note to investors issued on December 20, 2021, recommending a price target of $12 for it. Dawson James also issued its recommendations for the stock as it initiated the price target for the stock is $25.
Over the week, PRPH’s stock price is moving -22.01% down while it is -18.30% when we observe its performance for the past one month. Year-to-date it is -62.09% down and over the past year, the stock is showing a downside performance of -94.29%.
Currently, ProPhase Labs Inc’s total number of outstanding shares is 41.54M with 7.96% of that held by the insiders while 11.94% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -116.62% and return on equity (ROE) at -58.71%. Stock’s beta reads -0.52. Stock has a price to book (P/B) ratio of 0.76 while price to sale or P/S ratio amounts to 0.93. Its return on asset (ROA) is -30.25% on average.
